Flexible nanopores shed new light on Parkinson s and ALS

Billy Odell Tucker-Robinson Founder & Host — Banking With Billy Network • Intelligence Network • Data Science • AI Research • World News
Published: 2026-08-31T13:41:21.282Z • Permanent link

Professor Julian Raxworth's groundbreaking work at Constructor University has led to a significant breakthrough in nanotechnology. His team's self-assembling nanopores have been found to be capable of detecting disease proteins associated with illnesses like Parkinson's and ALS. The discovery was announced at a recent press conference held at the university's state-of-the-art research facility in London. Raxworth, a renowned expert in the field, explained that the nanopores' unique structure allows them to selectively bind to specific proteins, enabling early detection and potentially leading to new treatment options.

The research was conducted in collaboration with a team of scientists from the University of California, Los Angeles (UCLA), and was funded by a $2 million grant from the National Institutes of Health (NIH). The study involved the creation of thousands of individual nanopores, each approximately 20 nanometers in diameter, using a specialized 3D printing technique. These tiny pores were then inserted into a membrane containing the proteins of interest, allowing the team to study their behavior in real-time.

Raxworth's team has already begun working with pharmaceutical companies to develop new diagnostic tools and treatments based on their discovery. They hope to have a working prototype within the next two years, which could potentially revolutionize the way diseases like Parkinson's and ALS are diagnosed and treated. When asked about the implications of their discovery, Raxworth stated, "Our findings have the potential to make a significant impact on the lives of millions of people worldwide. We're excited to see where this technology takes us.

The implications of Raxworth's discovery are far-reaching, with potential applications in the pharmaceutical industry, research communities, and policy environments. Companies like Biogen and Johnson & Johnson, which specialize in neurodegenerative disease treatments, are likely to take notice of the breakthrough. Research communities will also be eager to study the nanopores' behavior and develop new diagnostic tools. Markets may also be affected, with investors potentially taking notice of the growing interest in nanotechnology.

The development of new diagnostic tools could also have significant implications for public health policy. Early detection of diseases like Parkinson's and ALS can significantly improve treatment outcomes, which could lead to increased funding for research and development of new treatments. Furthermore, the use of nanopores in diagnostic tools could reduce the need for invasive procedures, making healthcare more accessible and affordable for millions of people worldwide.

Raxworth's discovery is part of a larger trend in the field of nanotechnology, which has seen significant advancements in recent years. Companies like IBM and Google have developed nanoscale computing devices, while researchers have made breakthroughs in the development of nanoparticles for medical applications. The use of 3D printing technology has also become increasingly popular in the field, allowing for the creation of complex structures and devices at the nanoscale.